Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health Population

This study has been completed.
Sponsor:
Collaborators:
Ontario Ministry of Health and Long Term Care
Western Ontario Therapeutic Community Hostel (WOTCH)
Canadian Mental Health Association
London Intercommunity Health Centre (LIHC)
Information provided by:
Lawson Health Research Institute
ClinicalTrials.gov Identifier:
NCT00253240
First received: November 10, 2005
Last updated: July 20, 2007
Last verified: July 2007
  Purpose

Family physicians are the primary health care providers for complex patients such as persons with serious mental illness. The psychiatric needs of these patients could take attention away from management of health problems and from usual health promotion services. For example, Schizophrenia is associated with a higher than normal incidence of diabetes, and first line treatments of Schizophrenia have also been found to increase risk for diabetes. As such, this high-risk group requires targeted diabetes strategies. In London Ontario, services are provided to this high risk mental health population primarily by two community agencies: The Western Ontario Therapeutic Community Hostel (WOTCH) and the Canadian Mental Health Association (CMHA). Accordingly, the goal of this project is to assess how these patients are currently being managed by their family physicians and to pilot a community-based, multidisciplinary diabetes clinic model within this population. If this delivery model proves feasible and effective, family physicians could be assisted by existing community agencies in the management of their patients’ diabetes and patients will receive improved access to this vital multidisciplinary team.


Condition Intervention Phase
Diabetes Mellitus
Schizophrenia
Psychotic Disorders
Procedure: Screening
Procedure: Management
Phase 3

Study Type: Observational
Study Design: Primary Purpose: Screening
Time Perspective: Longitudinal
Official Title: Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health Population - An Evaluation Project

Resource links provided by NLM:


Further study details as provided by Lawson Health Research Institute:

Enrollment: 75
Study Start Date: September 2004
Study Completion Date: September 2005
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Active in current WOTCH/CMHA database with listed diagnosis of a psychotic disorder an or use of Novel Antipsychotics. Must have Family Physician contact.

Exclusion Criteria:

  • any patient with declaration on file stating incapable of consenting to treatment.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00253240

Locations
Canada, Ontario
London Intercommunity Health Centre
London, Ontario, Canada, N5W 2Z1
Sponsors and Collaborators
Lawson Health Research Institute
Ontario Ministry of Health and Long Term Care
Western Ontario Therapeutic Community Hostel (WOTCH)
Canadian Mental Health Association
London Intercommunity Health Centre (LIHC)
Investigators
Principal Investigator: David RS Haslam, MSc MD FRCPC Regional Mental Health Care, London
Principal Investigator: Stewart B Harris, MD MPH CCFP FACPM Centre for Studies in Family Medicine
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00253240     History of Changes
Other Study ID Numbers: R-04-441, G13-05457, 10933E, LRI7760576
Study First Received: November 10, 2005
Last Updated: July 20, 2007
Health Authority: Canada: Health Canada

Additional relevant MeSH terms:
Diabetes Mellitus
Mental Disorders
Psychotic Disorders
Schizophrenia
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Schizophrenia and Disorders with Psychotic Features

ClinicalTrials.gov processed this record on November 27, 2014